Denis R Burger - Net Worth and Insider Trading

Denis R Burger Net Worth

The estimated net worth of Denis R Burger is at least $3 Million dollars as of 2024-05-11. Denis R Burger is the CEO of Sarepta Therapeutics Inc and owns about 25,286 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $3 Million. Denis R Burger is also the Director of Aptose Biosciences Inc and owns about 2,111 shares of Aptose Biosciences Inc (APTO) stock worth over $2,597. Details can be seen in Denis R Burger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Denis R Burger has not made any transactions after 2021-12-20 and currently still holds the listed stock(s).

Transaction Summary of Denis R Burger

To

Denis R Burger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Denis R Burger owns 3 companies in total, including Aptose Biosciences Inc (APTO) , CytoDyn Inc (CYDY) , and Sarepta Therapeutics Inc (SRPT) .

Click here to see the complete history of Denis R Burger’s form 4 insider trades.

Insider Ownership Summary of Denis R Burger

Ticker Comapny Transaction Date Type of Owner
APTO Aptose Biosciences Inc 2021-12-20 director
CYDY CytoDyn Inc 2014-02-18 director
SRPT Sarepta Therapeutics Inc 2007-04-03 director & Chief Executive Officer

Denis R Burger Latest Holdings Summary

Denis R Burger currently owns a total of 2 stocks. Among these stocks, Denis R Burger owns 25,286 shares of Sarepta Therapeutics Inc (SRPT) as of August 13, 2004, with a value of $3 Million and a weighting of 99.92%. Denis R Burger also owns 2,111 shares of Aptose Biosciences Inc (APTO) as of December 20, 2021, with a value of $2,597 and a weighting of 0.08%.

Latest Holdings of Denis R Burger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SRPT Sarepta Therapeutics Inc 2004-08-13 25,286 131.82 3,333,201
APTO Aptose Biosciences Inc 2021-12-20 2,111 1.23 2,597

Holding Weightings of Denis R Burger


Denis R Burger Form 4 Trading Tracker

According to the SEC Form 4 filings, Denis R Burger has made a total of 0 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years. The most-recent trade in Sarepta Therapeutics Inc is the acquisition of 3,333 shares on August 13, 2004, which cost Denis R Burger around $35,000.

According to the SEC Form 4 filings, Denis R Burger has made a total of 1 transactions in Aptose Biosciences Inc (APTO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aptose Biosciences Inc is the acquisition of 667 shares on December 20, 2021, which cost Denis R Burger around $14,500.

Insider Trading History of Denis R Burger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Denis R Burger Trading Performance

GuruFocus tracks the stock performance after each of Denis R Burger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Denis R Burger is -14.66%. GuruFocus also compares Denis R Burger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Denis R Burger within 3 months outperforms 1 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Denis R Burger's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Denis R Burger

Average Return

Average return per transaction

Outperforming Transactions

3 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.93
Relative Return to S&P 500(%) 2.36

Denis R Burger Ownership Network

Ownership Network List of Denis R Burger

No Data

Ownership Network Relation of Denis R Burger


Denis R Burger Owned Company Details

What does Aptose Biosciences Inc do?

Who are the key executives at Aptose Biosciences Inc?

Denis R Burger is the director of Aptose Biosciences Inc. Other key executives at Aptose Biosciences Inc include director & Chair & President & CEO William G. Rice , SR VP & Chief Fin. Officer Fletcher Payne , and Chief Commercial Officer Philippe Ledru .

Aptose Biosciences Inc (APTO) Insider Trades Summary

Over the past 18 months, Denis R Burger made no insider transaction in Aptose Biosciences Inc (APTO). Other recent insider transactions involving Aptose Biosciences Inc (APTO) include a net purchase of 17,000 shares made by Bernd R. Seizinger ,

In summary, during the past 3 months, insiders sold 0 shares of Aptose Biosciences Inc (APTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptose Biosciences Inc (APTO) were sold and 17,000 shares were bought by its insiders, resulting in a net purchase of 17,000 shares.

Aptose Biosciences Inc (APTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aptose Biosciences Inc Insider Transactions

No Available Data

Denis R Burger Mailing Address

Above is the net worth, insider trading, and ownership report for Denis R Burger. You might contact Denis R Burger via mailing address: Cytodyn Inc., 1111 Main Street, Suite 660, Vancouver Wa 98660.

Discussions on Denis R Burger

No discussions yet.